ferrous sulfate has been researched along with epoetin alfa in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McClelland, B | 1 |
| Adamson, J | 2 |
| Gombotz, H | 1 |
| Audo, A; Barberis, L; Carmagnini, E; Crivellari, R; Dottori, V; Lijoi, A; Parodi, E; Passerone, G; Podestà, A | 1 |
| Crivellari, R; Dottori, V; Parodi, E; Passerone, GC; Podestà, A | 1 |
| Auerbach, MA; Dahl, NV; Henry, DH | 1 |
| Lynn, S; McDaniel, J | 1 |
| Gonzalez-Zayaz, P; Tasch, J | 1 |
| Biboulet, P; Bringuier, S; Capdevila, X; Dangelser, G; Loupec, T; Maissiat, G; Pencole, M; Smilevitch, P; Thuile, C | 1 |
1 review(s) available for ferrous sulfate and epoetin alfa
| Article | Year |
|---|---|
Potential of epoetin alfa in patients in autologous blood donation programs for orthopedic surgery.
Topics: Anemia; Blood Transfusion, Autologous; Epoetin Alfa; Erythropoiesis; Erythropoietin; Ferrous Compounds; Hematocrit; Hemoglobins; Humans; Injections, Intravenous; Injections, Subcutaneous; Orthopedics; Premedication; Recombinant Proteins | 1996 |
6 trial(s) available for ferrous sulfate and epoetin alfa
| Article | Year |
|---|---|
Potential of epoetin alfa in patients in autologous blood donation programs for orthopedic surgery.
Topics: Anemia; Blood Transfusion, Autologous; Epoetin Alfa; Erythropoiesis; Erythropoietin; Ferrous Compounds; Hematocrit; Hemoglobins; Humans; Injections, Intravenous; Injections, Subcutaneous; Orthopedics; Premedication; Recombinant Proteins | 1996 |
Epoetin alfa as an adjunct to autologous blood donation in patients with a low hematocrit scheduled for elective orthopedic surgery.
Topics: Anemia; Blood Transfusion; Blood Transfusion, Autologous; Double-Blind Method; Elective Surgical Procedures; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferrous Compounds; Hematocrit; Humans; Male; Orthopedics; Premedication; Recombinant Proteins; Treatment Outcome | 1996 |
Perisurgical use of epoetin alfa in orthopedic surgery patients.
Topics: Anemia; Blood Transfusion; Dose-Response Relationship, Drug; Double-Blind Method; Elective Surgical Procedures; Epoetin Alfa; Erythropoiesis; Erythropoietin; Ferrous Compounds; Humans; Injections, Subcutaneous; Orthopedics; Premedication; Recombinant Proteins; Transferrin; Treatment Outcome | 1996 |
Elective coronary and valve surgery without blood transfusion in patients treated with recombinant human erythropoietin (epoetin-alpha).
Topics: Blood Loss, Surgical; Coronary Disease; Elective Surgical Procedures; Epoetin Alfa; Erythropoietin; Female; Ferrous Compounds; Heart Valve Diseases; Hematinics; Humans; Male; Middle Aged; Recombinant Proteins | 2000 |
Epoetin alpha in elective coronary and valve surgery in Jehovah's Witnesses patients. Experience in 45 patients.
Topics: Administration, Oral; Aged; Anemia, Hypochromic; Blood Transfusion; Christianity; Coronary Artery Bypass; Elective Surgical Procedures; Epoetin Alfa; Erythropoietin; Female; Ferrous Compounds; Heart Valve Prosthesis Implantation; Heart Valves; Hematinics; Hematocrit; Hemoglobins; Humans; Male; Middle Aged; Recombinant Proteins; Religion and Medicine; Treatment Outcome; Vascular Surgical Procedures | 2002 |
Preoperative Epoetin-α with Intravenous or Oral Iron for Major Orthopedic Surgery: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Drug Therapy, Combination; Epoetin Alfa; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Humans; Iron; Male; Maltose; Middle Aged; Orthopedic Procedures; Postoperative Complications; Preoperative Care; Prospective Studies; Single-Blind Method | 2018 |
4 other study(ies) available for ferrous sulfate and epoetin alfa
| Article | Year |
|---|---|
Subcutaneous epoetin alfa as an adjunct to autologous blood donation before elective coronary artery bypass graft surgery.
Topics: Anemia; Blood Transfusion, Autologous; Coronary Artery Bypass; Elective Surgical Procedures; Epoetin Alfa; Erythropoiesis; Erythropoietin; Ferrous Compounds; Hemodilution; Hemoglobins; Humans; Injections, Subcutaneous; Male; Premedication; Recombinant Proteins; Treatment Outcome | 1996 |
Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron.
Topics: Aged; Anemia; Anemia, Iron-Deficiency; Antineoplastic Agents; Double-Blind Method; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Iron; Male; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Neoplasms; Randomized Controlled Trials as Topic; Recombinant Proteins; Retrospective Studies; Thrombocytosis; Thrombophilia; Venous Thromboembolism | 2012 |
Managing severe anemia when the patient is a Jehovah's Witness.
Topics: Adult; Anemia, Iron-Deficiency; Epoetin Alfa; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Fluid Therapy; Glucaric Acid; Hematinics; Humans; Jehovah's Witnesses; Male; Oxygen Inhalation Therapy; Recombinant Proteins; Severity of Illness Index; Vitamin B 12; Vitamin B Complex | 2013 |
Ceftriaxone-Induced Hemolytic Anemia in a Jehovah's Witness.
Topics: Aged; Anemia, Hemolytic; Anti-Bacterial Agents; Ceftriaxone; Endocarditis, Bacterial; Epoetin Alfa; Female; Ferrous Compounds; Folic Acid; Hematinics; Humans; Jehovah's Witnesses; Vitamin B 12 | 2017 |